{"schema_version":"secwatch.filing_event.v1","accession":"0000078003-26-000085","form_type":"8-K","ticker":"PFE","cik":"0000078003","company_name":"PFIZER INC","filed_at":"2026-06-18T11:07:07+00:00","discovered_at":"2026-06-18T11:10:00.308464+00:00","generated_at":"2026-06-18T11:10:04.798257+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pfizer CFO Dave Denton to step down Aug 15; Cecile Guegan named interim CFO","bullets":["Dave Denton to step down as CFO effective August 15, 2026, for a consumer goods opportunity.","Departure not related to Pfizer's financial or operating results or any disagreements.","Cecile Guegan, SVP Finance, Global Biopharm Business, named interim CFO effective August 16.","Pfizer will conduct internal and external search for permanent CFO.","Guegan has over 20 years at Pfizer, led Seagen integration."],"urls":{"canonical":"https://secwatch.observer/filing/0000078003-26-000085","json":"https://secwatch.observer/filing/0000078003-26-000085.json","markdown":"https://secwatch.observer/filing/0000078003-26-000085.md","text":"https://secwatch.observer/filing/0000078003-26-000085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/pfe-20260618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T11:10:04.798257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"047f240a75","claim":"Cecile Guegan was appointed as Interim Chief Financial Officer at PFIZER INC.","evidence_excerpt":"the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e9fcf8c3d4","claim":"Dave Denton departed as Chief Financial Officer at PFIZER INC.","evidence_excerpt":"Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"step down"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}